POST Online Media Lite Edition


Vermillion appoints chairman of board as president and CEO

Staff writer |
Austin, Tx., USA - April 24, 2014, Austin, Tx., USA - Vermillion, Inc., a molecular diagnostics company, has appointed James LaFrance as president and chief executive officer.

Article continues below

Prior to joining Vermillion, Mr. LaFrance served as CEO of Omnyx, a joint venture of GE and UPMC in Pittsburgh. He held executive leadership positions with Ventana Medical Systems (now part of Roche Diagnostics) in global marketing and business development, as well as domestic and international commercial general management.

Prior to Ventana, Mr. LaFrance led global marketing and business development for the Near Patient Testing division of Bayer Diagnostics (now part of Siemens). He holds a Masters of Business Administration from the University of Notre Dame, Mendoza School of Business, and a Bachelor of Arts in economics from the University of Connecticut.


What to read next

Vermillion appoints Eric Varma to board
Vermillion appoints COO
Vermillion appoints Bruce A. Huebner as interim CEO